| 22465430 | Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. | Gastroenterology | 2012 Jul | Manieri NA | doi: 10.1053/j.gastro.2012.03.037 |
| 18547613 | Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. | Hum Pathol | 2008 Aug | Li L | doi: 10.1016/j.humpath.2007.12.012 |
| 21838610 | Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer. | Biotech Histochem | 2012 Jan | Findeis-Hosey JJ | doi: 10.3109/10520295.2011.591831 |
| 31118463 | Combinatorial recognition of clustered RNA elements by the multidomain RNA-binding protein IMP3. | Nat Commun | 2019 May 22 | Schneider T | doi: 10.1038/s41467-019-09769-8. |
| 22536444 | PKCα binds G3BP2 and regulates stress granule formation following cellular stress. | PLoS One | 2012 | Kobayashi T | doi: 10.1371/journal.pone.0035820 |
| 20178612 | Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. | BMC Cancer | 2010 Feb 23 | Schaeffer DF | doi: 10.1186/1471-2407-10-59. |
| 29212181 | Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability. | Oncotarget | 2017 Sep 27 | Zhao W | doi: 10.18632/oncotarget.21280 |
| 23640942 | Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains. | Biol Chem | 2013 Aug | Wachter K | doi: 10.1515/hsz-2013-0111. |
| 28481226 | Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition. | J Clin Invest | 2017 Jun 1 | Elagib KE | doi: 10.1172/JCI88936 |
| 30135093 | Structural basis of IMP3 RRM12 recognition of RNA. | RNA | 2018 Dec | Jia M | doi: 10.1261/rna.065649.118 |
| 16049158 | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | Reproduction | 2005 Aug | Hammer NA | - |
| 23069990 | Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? | Cell Mol Life Sci | 2013 Aug | Bell JL | doi: 10.1007/s00018-012-1186-z |
| 19357927 | Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma. | Ann Surg Oncol | 2009 Jun | Yuan RH | doi: 10.1245/s10434-009-0446-0 |
| 19192721 | Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma. | Oncol Res | 2008 | Do SI | - |
| 18802962 | RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. | Hepatology | 2008 Oct | Jeng YM | doi: 10.1002/hep.22459. |
| 18499984 | Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas. | Acta Cytol | 2008 Mar-Apr | Yantiss RK | - |
| 21757716 | RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. | J Biol Chem | 2011 Sep 9 | Liao B | doi: 10.1074/jbc.M111.263913 |
| 23246869 | Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma. | Int J Surg | 2013 | Chen YL | doi: 10.1016/j.ijsu.2012.11.021 |
| 24135846 | Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma. | J Neurooncol | 2014 Jan | Zhou M | doi: 10.1007/s11060-013-1274-4 |
| 23647076 | Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma. | J Oral Pathol Med | 2011 Oct | Lin CY | doi: 10.1111/j.1600-0714.2011.01019.x |
| 27510448 | CircRNA-protein complexes: IMP3 protein component defines subfamily of circRNPs. | Sci Rep | 2016 Aug 11 | Schneider T | doi: 10.1038/srep31313. |
| 26796627 | Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma. | PLoS One | 2016 Jan 21 | Sheen YS | doi: 10.1371/journal.pone.0147431 |
| 25794352 | RELB Alters Proliferation of Human Pluripotent Stem Cells via IMP3- and LIN28-Mediated Modulation of the Expression of IGF2 and Other Cell-Cycle Regulators. | Stem Cells Dev | 2015 Aug 15 | Thakar NY | doi: 10.1089/scd.2014.0587 |
| 28465487 | IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65. | Oncotarget | 2017 Jun 20 | Bhargava S | doi: 10.18632/oncotarget.17118. |
| 12806623 | Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas. | Gastroenterology | 2003 Jun | Wagner M | - |
| 11713986 | A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. | Scand J Clin Lab Invest Suppl | 2001 | Nielsen FC | - |
| 11465943 | Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies. | Clin Immunol | 2001 Aug | Zhang JY | - |
| 15753088 | The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. | J Biol Chem | 2005 May 6 | Liao B | - |
| 15601260 | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | Biol Cell | 2005 Jan | Yisraeli JK | - |
| 16814207 | Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. | Lancet Oncol | 2006 Jul | Jiang Z | - |
| 20060157 | IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology. | Hum Pathol | 2010 May | Ikeda K | doi: 10.1016/j.humpath.2009.04.030 |
| 18835627 | Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas. | Hum Pathol | 2009 Feb | Pryor JG | doi: 10.1016/j.humpath.2008.07.009 |
| 17521698 | Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not. | Hum Pathol | 2007 Aug | Simon R | - |
| 22840368 | Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. | Eur J Cancer | 2012 Dec | Lochhead P | doi: 10.1016/j.ejca.2012.06.021 |
| 22646265 | Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. | Arch Pathol Lab Med | 2012 Jun | Liu H | doi: 10.5858/arpa.2011-0326-OA. |
| 21809995 | The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma. | Arch Pathol Lab Med | 2011 Aug | Hao S | doi: 10.5858/2009-0652-OAR2. |
| 21613208 | Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2. | J Biol Chem | 2011 Jul 22 | Suvasini R | doi: 10.1074/jbc.M110.178012 |
| 25499221 | KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells. | Neoplasia | 2014 Dec | Taniuchi K | doi: 10.1016/j.neo.2014.10.007. |
| 24713990 | Oncofetal protein IMP3, a new cancer biomarker. | Adv Anat Pathol | 2014 May | Gong Y | doi: 10.1097/PAP.0000000000000021. |
| 24615121 | Prognostic value of tissue and circulating levels of IMP3 in prostate cancer. | Int J Cancer | 2014 Oct 1 | Szarvas T | doi: 10.1002/ijc.28808 |
| 24411949 | Insulin-like growth factor II messenger RNA-binding protein 3 expression in gastrointestinal mesenchymal tumors. | Hum Pathol | 2014 Mar | Yamamoto H | doi: 10.1016/j.humpath.2013.10.010 |
| 24388440 | Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. | Eur Urol | 2014 Aug | Lee DJ | doi: 10.1016/j.eururo.2013.12.008 |
| 24343741 | Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. | Am J Clin Pathol | 2014 Jan | Minato H | doi: 10.1309/AJCP5KNL7QTELLYI. |
| 23808460 | Clinical implications of current developments in genitourinary pathology. | Arch Pathol Lab Med | 2013 Jul | Zhou AG | doi: 10.5858/arpa.2012-0210-RA. |
| 23597774 | Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm. | Hum Pathol | 2013 Sep | Morimatsu K | doi: 10.1016/j.humpath.2012.12.020 |
| 23465280 | Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance. | Hum Pathol | 2013 Aug | Fadare O | doi: 10.1016/j.humpath.2012.12.003 |
| 26982091 | The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB. | Elife | 2016 Mar 16 | Schmiedel D | doi: 10.7554/eLife.13426. |
| 26974154 | RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. | J Clin Invest | 2016 Apr 1 | Palanichamy JK | doi: 10.1172/JCI80046 |
| 26379850 | Diagnostic value of IMP3 in pancreatic cancer: a meta-analysis. | Int J Clin Exp Med | 2015 Jul 15 | Wang Q | - |
| 26158423 | Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer. | Br J Cancer | 2015 Jul 28 | Hsu KF | doi: 10.1038/bjc.2015.254 |
| 28381175 | Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer. | Tumour Biol | 2017 Apr | Shi R | doi: 10.1177/1010428317695928. |
| 27900001 | Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1α and malignant potential in pancreatic neuroendocrine tumors. | Oncol Lett | 2016 Nov | Fujino M | - |
| 29077232 | Insulin-like growth factor II messenger RNA-binding protein-3 is an independent prognostic factor in uterine leiomyosarcoma. | Histopathology | 2018 Apr | Yasutake N | doi: 10.1111/his.13422 |
| 29114069 | BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells. | J Cell Biol | 2017 Dec 4 | An MX | doi: 10.1083/jcb.201701064 |
| 27438513 | IMP3 Immunohistochemical Expression Remains Consistent Among All Grades of Gastrointestinal Neuroendocrine Tumors. | Appl Immunohistochem Mol Morphol | 2018 Apr | Agostini-Vulaj D | doi: 10.1097/PAI.0000000000000416. |
| 29703820 | Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy. | Clin Cancer Res | 2018 Aug 1 | Mancarella C | doi: 10.1158/1078-0432.CCR-17-2602 |
| 30098092 | Measurement of telomere length in cells from pleural effusion: Asbestos exposure causes telomere shortening in pleural mesothelial cells. | Pathol Int | 2018 Sep | Aida S | doi: 10.1111/pin.12710 |
| 30670575 | Dysregulated activation of fetal liver programme in acute liver failure. | Gut | 2019 Jun | Hyun J | doi: 10.1136/gutjnl-2018-317603 |
| 30895618 | Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo. | J Cell Physiol | 2019 Aug | Xu W | doi: 10.1002/jcp.28483 |
| 30951723 | Loss of Gsdf leads to a dysregulation of Igf2bp3-mediated oocyte development in medaka. | Gen Comp Endocrinol | 2019 Jun 1 | Wu X | doi: 10.1016/j.ygcen.2019.04.001 |
| 31277094 | IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype. | Medicine (Baltimore) | 2019 Jul | Yang F | doi: 10.1097/MD.0000000000016009. |
| 30797711 | Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation. | EBioMedicine | 2019 Mar | Wang Z | doi: 10.1016/j.ebiom.2018.12.061 |
| 19734845 | Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes. | Mod Pathol | 2009 Dec | Mentrikoski MJ | doi: 10.1038/modpathol.2009.128 |
| 18204432 | IMP-3 is a novel progression marker in malignant melanoma. | Mod Pathol | 2008 Apr | Pryor JG | doi: 10.1038/modpathol.3801016 |
| 30243807 | The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications. | Pathol Res Pract | 2018 Nov | Cen WN | doi: 10.1016/j.prp.2018.09.010 |
| 19698973 | IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue. | Hum Pathol | 2009 Dec | King RL | doi: 10.1016/j.humpath.2009.05.003 |
| 22012575 | Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma. | J Surg Oncol | 2012 Jun 15 | Okada K | doi: 10.1002/jso.22108 |
| 25176620 | IMP3 expression is associated with poor survival in cervical squamous cell carcinoma. | Hum Pathol | 2014 Nov | Wei Q | doi: 10.1016/j.humpath.2014.07.006 |
| 23845468 | IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma. | Hum Pathol | 2013 Oct | Tang H | doi: 10.1016/j.humpath.2013.04.011 |
| 26624896 | Positive Surgical Margin, HPV Persistence, and Expression of Both TPX2 and PD-L1 Are Associated with Persistence/Recurrence of Cervical Intraepithelial Neoplasia after Cervical Conization. | PLoS One | 2015 Dec 1 | Zhang H | doi: 10.1371/journal.pone.0142868 |
| 29731738 | Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R. | Front Endocrinol (Lausanne) | 2018 Apr 20 | Mancarella C | doi: 10.3389/fendo.2018.00178 |
